MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202421037185 A) filed by Sun Pharmaceutical Industries Limited, Maharashtra, on May 10, 2024, for 'crystalline polymorph and co-crystals of pirtobrutinib, processes for their preparation and pharmaceutical compositions thereof.'
Inventor(s) include Santra Ram Kinker; Kanawade Sandeep T; Shankar Durga; Shah Jigar; Rai Bishwa Prakash; Nath Asok; and Prasad Mohan.
The application for the patent was published on Nov. 14, under issue no. 46/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to crystalline forms of Pirtobrutinib, co-crystals comprising Pirtobrutinib and a co-crystal former, wherein the co-crystal former is selected from the group consisting of glutaric acid, oxalic acid, and L-tryptophan, processes for their preparation, pharmaceutical formulations, and therapeutic uses thereof. The invention further relates to an improved process for the preparation of Pirtobrutinib and intermediates thereof."
Disclaimer: Curated by HT Syndication.
